Karen Malkhasyan, MD

Articles by Karen Malkhasyan, MD

The Use of Serum hCG as a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy

ByKaren Malkhasyan, MD,Hari A. Deshpande, MD,Adebowale J. Adeniran, MD,John W. Colberg, MD,Daniel P. Petrylak, MD

October 15th 2013

A 55-year-old woman with a history of metastatic melanoma in remission for 8 years presented to the emergency department with gross hematuria. A CT scan, ordered because the patient was in menopause, demonstrated a bladder tumor.

Latest Updated Articles

The Use of Serum hCG as a Marker of Tumor Progression and of the Response of Metastatic Urothelial Cancer to Systemic Chemotherapy
October 15th 2013

Trending on CancerNetwork

Pirtobrutinib Earns Positive CHMP Opinion Across All CLL Treatment Lines

Generic Enzalutamide Receives Tentative FDA Approval in Prostate Cancer

40 An AI Digital Twin Compares Favorably to Radiologists for Landmark Identification and Measurement in Early-Stage Breast Cancer: A Retrospective, Multi-Institution Clinical Study